Skip to main content
. 2015 Aug 21;88(1054):20140736. doi: 10.1259/bjr.20140736

Table 2.

Necessary dose–volume constraints for planning approval of Hom (D2% ≤ 37.5 Gy) and Het (D2% ≤ 40.2 Gy) plans

Volume Hom plans Any plan Het plans
sub-PTV D98% ≥ 33.2 Gy   D98% ≥ 35 Gy
Dmean = 35 Gy   Dmean = 37.5 Gy
D2% ≤ 37.5 Gy   D2% ≤ 40.2 Gy
PTV   V33.2PTV ≥ 95%  
D2% ≤ 37.5 Gy   D2% ≤ 40.2 Gy
OVLrectum, OVLbladder, OVLPRV-u   D1cm3 < 35 Gy  
  D98% ≥ 32 Gy  
Rectuma   D1cm3 < 35 Gy  
  V32r < 5%  
  V28r < 10%  
  V18r < 35%  
Femoral heads   D1cm3 < 20 Gy  

Dmean, mean dose of the structure; Dn%, minimum dose to n% of the structure; OVLbladder, overlap between PTV and bladder; OVLPRV-u, overlap between PTV and urethral-PRV; OVLrectum, overlap between PTV and rectum; PRV, planning at risk volume; PTV, planning target volume; sub-PTV, planning target volume minus OVLrectum, OVLbladder, and OVLPRV-u; VmPTV, percentage of PTV structure receiving ≥m (Gy); Vmr, percentage of rectal structure receiving ≥m (Gy).

a

For plans computed on a CT study which was scanned after the insertion of a rectal spacer, a <1 cm3 extension for OVLrectum may result. In this case, the D1cm3 < 35 Gy constraint is applied to the whole rectum. As the extensions of OVLbladder and OVLPRV-u are always >1 cm3, the use of the D1cm3 < 35 Gy constraint to the overlaps assures the fulfilment of the same constraint to the whole organ.